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Effect of l,25-dihydroxyvitamin D3 on cytosolic calcium in dispersed
parathyroid cells. We examined the effect of I ,25-dihydroxyvitamin D3
(l,25(OH)2D3)on cytosolic calcium ([Ca]1) of dispersed bovine parathy-
roid cells, using the fluorescent dye indo-l. The addition of 10-8 M
l,25-(OH)2D3 caused an increase in [Ca] by 23.4 2.7% over a 10
minute period. There was a significant increase in [Ca]1 within two
minutes of the addition of I ,25-(OH)2D3. I ,25-(OH)2D increased [Ca]1
in a dose-dependent manner and this occurred with as little as 10—10 M.
Neither IO M 25-(OH)D3 nor lO M 24, 25-(OH)2D3 caused a
significant increase in [Ca]. Chelation of extracellular calcium with
EGTA blocked the l,25-(OH)2D3-induced increase in [Ca]1, suggesting
that the increase was mainly from extracellular calcium. Neither l0 M
verapamil nor iO M diltiazem blocked the l,25-(OH)2D3-induced
increase in [Ca]1. The present data suggest that I ,25-(OH)2D3 might
modify membrane permeability to calcium independent of voltage-
dependent calcium channels sensitive to verapamil or diltiazem. The
rapid effect of 1,25-(OH)2D3 raises the possibility that its mechanism is
independent of genome activation, perhaps attributable to direct inter-
action with components of the parathyroid cell plasma membrane.
Current evidence indicates that I ,25-(OH)2D3 has some effect
in tissues other than bone, intestine and kidney. Since the
parathyroid gland possesses specific receptors for 1,25-
(OH)2D3 and a calcium binding protein [1,2], it is considered
to be a target organ for I ,25-(OH)2D3. Recent studies in our
laboratory demonstrated that 1 ,25-(OH)2D3 itself suppressed
parathyroid hormone (PTH) secretion in vivo and in vitro [3,4].
We observed that in 20 patients on maintenance hemodialysis,
thrice weekly intravenous l,25-(OH)2D3 administered after
each dialysis resulted in a fall in serum iPTH levels before any
changes in serum calcium concentration [3]. We [4] and others
[5], moreover, demonstrated the suppressive effect of long term
(more than 24hr) incubation with I,25-(OH)2D3 on PTH secre-
tion in cultured bovine parathyroid cells. Short term (less than
4hr) effect of I ,25-(OH),D3 on PTH secretion could not be
observed [6], however, all the mechanisms by which
l,25-(OH)2D3 affects PTH secretion remain unclear. As an
intracellular messenger of hormone action cytosolic calcium
[Cal1 is critically important [7—11]. Alteration in [Ca]1 concen-
tration are instrumental in the control of hormone secretion and
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synthesis. As for parathyroid cells, levels of [Cal1 have recently
been shown to be correlated with changes in extracellular
calcium, suggesting that [Ca]1 may be an important component
in regulating PTH secretion [12]. However, there is also recent
evidence that while increased [Cal1 is often paralleled by a
reduction in secreton of PTH, the two responses can be readily
dissociated [13—16]. Since Rasmussen and coworkers demon-
strated a direct rapid effect of I ,25-(OH)2D3 on lipid composi-
tion of intestinal brush border membrane and transcellular
transport of calcium [171, there have been many reports about
the rapid effect of 1,25-(OH)2D1 [18—21].
We examined the effect of vitamin D on [CaJ1 levels in
dispersed parathyroid cells. In the present studies we used one
of new generation of dyes, indo-l. As Grynkiewicz, Peonie and
Tsien reported, indo-l is a much more sensitive dye for the
measurement of [Ca]1 than quin-2 [22], which allows the effect
of l,25-(OH)2D3 on [Ca]1 to be more precisely investigated [17].
Using indo-1, we report that l,25-(OH)2D3 at near physiological
concentration rapidly increased [Ca], levels mainly due to an
increased influx of calcium.
Methods
Preparation of dispersed parathyroid cells
Bovine parathyroid glands were collected at a local abattoir
within five minutes of slaughter. Dispersed bovine parathyroid
cells were prepared according to the method of Brown et al with
minor modification [23,24]. The glands were trimmed of extra-
neous tissue, sliced to 0.5 mm thickness with a Stadie-Riggs
microtome and finely minced with scissors. Digestion media
was made by adding 2.5 mg collagenase and 10 Lg/ml DNAase
II to base media (116 mrvi NaCI, 5 mr't KCI, I ml NaH2PO4H2O,
20 msi Hepes, 0.5 mM CaCI2, 1.0 mrt MgCl2, 200 mg% glucose,
5.5, mri succinic acid disodium salt, 5 mri L-glutamic acid, and
5 mM lactic acid, pH 7.4). The finely minced parathyroid tissue
was added to the digestion media. Ten ml digestion medium was
used for I g tissue. The suspension was gassed with 100%
oxygen, capped and placed in a shaking water bath (100
cycles/mm) at 37°C for one hour. It was vigorously syringed
every 15 minutes. The digested tissue was filtered through fine
gauze and then nylon mesh. The cells were sedimented by
centrifugation for 10 minutes at 1500 rpm. These cells were
washed and sedimented by centrifugation for five minutes at
1500 rpm three times. The cells were then resuspended in base
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media containing 0.5% fetal calf serum. Cells with a 95%
viability, as assessed by trypan blue exclusion, were routinely
obtained.
Measurement off Ca]1
Dispersed cells were exposed to 3 M indo-l acetoxymethyl-
ester (indo-IAM) for 30 minutes. Indo-IAM entered the cells,
where cytoplasmic esterases converted it to free indo-l, the
calcium sensitive form. The cells were then washed for 10
minutes in a balanced salt solution (BSS) 127 mis'i NaCI, 3.8 mM
KCI, 1.2 mt KH2PO4, 0.5 mtvi CaCI2, 0.8 mrt MgCl2, 5 mM
glucose, 10 mi HEPES, adjusted to pH 7.4 with I M NaOH)
and transferred to a 1 cm plastic cuvette for fluorescence
measurement. Fluorescence was measured, using an SLM 4800
spectrofluorometer (SLM Instruments, Urbana Illinois, USA)
coupled to a computer. The cells were stirred continuously and
the cuvette holder thermostated to 37°C. The excition wave-
length was 355 nm (slit width 8 nm) and emission was simulta-
neously monitored at 400 nm (slit width 8 nm) using an SLM
monochromator and at 490 nm using an interference filter
(Corion Corp, Holliston, Massachusetts, USA). After subtrac-
tion of autofluorescence, the ratio of the emission at 400 nm to
that at 490 nm was calculated and the corresponding value of
[Ca]1 determined from the relationship [Ca]1 = Kd[(R-R min)/(R
max-R)J J3 [22], where R is the measured ratio and R mm and R
max are the values of R at very low and saturating concentra-
tions of calcium, respectively. f3 is the ratio of emission
intensities at 490 flM in these two sets of conditions. Two
cuvettes were alternately scanned for about four minutes in
order to establish a baseline value of [Ca],. Ethanol vehicle (2
jzl) was added to one cuvette (control) and indicated concen-
tration of vitamin D in 2 l ethanol was added to the other
curvette. The final concentration of ethanol was 0.1%. The
cuvettes were alternately scanned for an additional 10 minutes.
Calcium saturation of indo-l was achieved by elevating extra-
cellular calcium levels to more than 2 mrt, and then adding 5 LM
ionomycin and effectively zero calcium by the further addition
of 12.5 mrvt EGTA plus tris base to elevate the pH to greater
than 8.0. Cells were permeabilized with 40 mg/liter saponin
before the addition of EGTA to decrease the time necessary for
[Ca]1 to reach a minimum value. Kd, the dissociation constant
of indo-1 + Ca2, has been shown to be 250 nrvi [22]. The
leakage of indo-l from cells was checked by centrifuging
indo-l-loaded cell suspension and measuring the intensity of
fluorescence of the supernatant. Indo-IAM was dissolved in
DMSO, ionomycin in acetone.
lonomycin was obtained from Calbiochem (La Jolla, Califor-
nia, USA) indo-l acetoxymethylester from Molecular Probes
(Eugene, Oregon, USA) collagenase type 1 from Worthington
Biochemical Co. (Freehold, New Jersey, USA), DNAase II,
verapamil and diltiazem from Sigma Chemical Co. (St. Louis,
Missouri, USA) and I ,25-(OH)7D3, 24-25(OH),D3 and
25(OH)D3 from Hoffman-La Roche Inc. (Nutley, New Jersey).
Data are expressed as mean SEM. Student's t test was used
for the analysis of data.
Results
The basal levels of [Ca]1 in suspension of parathyroid cells
were found to be 293 5 nmol (N = 120), when the extracel-
lular calcium was 0.5 mi. Treatment of indo-l-loaded parathy-
roid cells incubated in medium containing 0.5 m calcium with
10_8 M l,25-(OH)2D3 for 10 minutes increased [Ca]1 of the cells.
Figure 1 shows the time course of ethanol- or j_8 M 1,25-
(OH)2D3-induced change in [Ca]1 levels. A significant difference
was found within two minutes and increased gradually during
the 10 minute period, compared with ethanol treated cells.
1 ,25-(OH)2D had no effect on autofluorescence. Table I shows
the dependency of the change in [Ca] on the dose of
I ,25-(OH)2D3. The change in [Ca]1 was expressed as percent
increase and [Ca]1 10 minutes after adding I ,25-(OH)2D3 or
ethanol. I ,25-(OH)2D3 increased [Cal1 in a dose-dependent
manner. A significant increase could be found at 10— 10 M
l,25-(OH),D3, a near physiological concentration. Similar ef-
fects were seen at 1.0 m and 2.0 mt extracellular calcium
concentration after the addition of 10—8 M I ,25-(OH)2D3. Basal
[Ca]1 422 22 (1.0 mM Ca) and 496 35 (2 mM Ca)
increased to 553 40 and 641 54 nmol, respectively.
In order to determine whether 1 ,25-(OH)2D3 increased [Ca]1
levels by increasing membrane transport of calcium or by







Fig. 1. Ti,ne course of I,25-(OH)2D3 induced increase in fCaJ1. 108 M
I,25-(OH)D1 (0, N = 14) or ethanol (•, N = 14) was added after
recording basal [Cal. Ca was expressed as the increase in [Ca] at the
indicated time. *P < 0.01 compared with control.
4 6 8 10
Time, mm
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Table 1. Dose-response relationship of 1,25(OH)2D3-induced in [Ca]1
N





























Vehiclel0 M 1,25(OH)2D1 II11 264 14265 14 304 16320 16 39.8 3.054.2 46b 15.2 0.820.5
Increase is expressed as the ratio of maximal [Ca]1 to basal [Ca]. Ca is expressed as the increase in [Cal1 levels 10 mm after adding indicated
concentration of 1,25(OH)2D3.
N indicates the number of experiments. Data are mean SEM.
a P < 0.01






Fig. 2. The effect of EGTA pretreatment of l,25-(OH)2D3-induced
increase in I Cal,. l0- M I ,25-(OH)2D1 (0, N = 5) or ethanol (I, N =
5) was added after the addition of 1 mat EGTA.
to chelate extracellular calcium prior to the addition of
1 ,25-(OH)2D3. As shown in Figure 2, the addition of EGTA
completely blocked 1 ,25-(OH)2D3-induced increase in [Ca]1. To
further investigate whether increased influx of calcium was via
voltage-dependent calcium channel, the effect of verapamil or
diltiazem pretreatment on I ,25-(OH)2D3-induced increase in
[Ca], was studied. Pretreatment with i05 M verapamil or l0—
Table 2. The effect of verapamil or diltiazem on l,25-(OH)2D3-
induced increase in [Cal,
Pretreatment Ca nmol Pretreatment Ca nmol
Control 98 6 Control 102 10
iO M verapamil 99 9 lO M diltiazem 97 6
Ca is expressed as the increase in [Cal levels 10 mm after addingiO M 1,25-(OH)2D1.
Data are mean SEM of five experiments.
Table 3. The effect of 24,25-(OH)2D1 or 25(OH)D5 on [Ca]1 levels
Treatment Ca nmol Treatment Ca nmol
Control (ethanol) 31 6 Control (ethanol) 32 4l0 M 24,25-(OH)2D3 32 3 l0— M 25-(OH)D3 31 4
Ca is expressed as the increase in [Ca], levels 10 minutes after
adding vitamin D3 metabolites or vehicle (ethanol). Data are mean
SEM of six experiments.
M diltiazem did not block 1 ,25-(OH)2D3-induced increase in
[Ca]1 levels (Table 2).
Since steroid hormones produce well known nonspecific
permeability effect on membranes, the effect of other vitamin D
metabolites on [Ca], levels was studied. Neither io— M
24,25(OH)2D3 nor l0- M 25-(OH)D3 significantly increased
[Ca], levels, compared to control, indicating specificity for
l,25-(OH)2D (Table 3).
Discussion
The present studies clearly demonstrated that 1 ,25-(OH)2D3
rapidly increased [Ca], levels over 10 minutes in a dose-
dependent manner, mainly due to increased influx of calcium.
This increase was found at almost physiological concentrations
and was specific for 1 ,25-(OH)2D3. I ,25-(OH)2D3 might modify
membrane permeability to calcium independent of voltage-
dependent calcium channels sensitive to verapamil or diltiazem.
Quin-2 has been extensively used as an indicator to measure
[Ca],, but the concentration of quin-2 necessary to measure
[Cal, results in the presence of a detrimental intracellular Ca2
buffer, thereby decreasing or abolishing the rapid increase in
[Ca]1. Grynkiewicz, Peonie and Tsien lately developed a new
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present studies [22]. Indo-l has two major advantages. Firstly,
its fluorescence intensity is thirtyfold greater, which allows
much lower dye concentrations to be used, resulting in a
decrease in the buffering of any change in [Ca]1 by the dye itself.
Loading cells with concentration of indo-l similar to those we
have used do not alter cellular integrity. In our studies cell
viability after loading with indo-1 was similar to controls (95%)
as assessed by trypan blue exclusion and phase contrast mi-
croscopy. In addition, the secretion of PTH from indo-l-loaded
cells was not different from that from control cells not loaded
with dye (data not shown). Secondly, the emission spectrum of
indo-l is changed by its interaction with calcium. The indo-l
calcium complex has a maximal fluorescence at 400 nm in
contrast to free indo-l which fluorescerices at 490 nm. Thus an
increase in [Ca]1 leads to increased fluorescence at 400 nm with
a decrease at 490 nm. The ratio of emission at these wave-
lengths shows a greater change than either parameter, resulting
in a further increase in the sensitivity. Basal levels of [Ca] were
always higher in cells loaded with indo-l, compared with those
which were reported in cells loaded with quin-2. However, our
data are compatible with those from recent report in which
fura-2, the same new generation indicator as indo-1, was used
[14].
We demonstrated that 1 ,25-(OH)2D3 had a rapid effect on
[Ca]1 levels in dispersed parathyroid cells. Vitamin D, being a
sterol, might be expected to have biological action that takes
place over hours rather than minutes. Since Rasmussen and
coworkers demonstrated that I ,25-(OH)2D3 per se rapidly af-
fected the lipid composition of intestinal brush border mem-
brane and thereby increased the transcellular calcium transport
[171, there have been many reports that l,25-(OH)2D3 affects
calcium transport rapidly in a variety of cell types [18—21]. This
effect in the intestinal cells did not require new protein synthe-
sis [17]. Moreover, recently l,25-(OH)2D3-induced effects on
hepatocyte and HL-60 cell [Ca]1 have been reported [25,26].
The time course and magnitude of increases in [Cal1 in our
studies are similar to those obtained from hepatocyte and
HL-60 cells. Our observations raise the possibility that the
mechanism is independent of genome activation, perhaps at-
tributed to a direct interaction with parathyroid cell membrane.
Hormone induced increases in [Cal1 are due to either trans-
port process across the plasma membrane or mobilization of
calcium from intracellular pools in the microsomes and
mitochondria. When the extracellular calcium concentration
was reduced abruptly by the addition of EGTA, the increase in
[Cal1 following I ,25-(OH)2D3 addition was completely blocked.
This indicates that the increase was mainly due to an influx of
calcium. This was further substantiated by the greater uptake
ot"5Ca by the parathyroid cells when treated with 1 ,25-(OH)2D3
in comparison with vehicle alone (data not shown). Our data are
compatible with the previous report by Rasmussen et at who
demonstrated that I ,25-(OH)2D3 rapidly increased the transcel-
lular transport of calcium [171. Pretreatment with calcium
channel blocker did not affect I ,25-(OH),D3-induced increases
in [Cal1, suggesting that the modification of membrane perme-
ability to calcium was independent of voltage-dependent cal-
cium channels sensitive to verpamil or diltiazem. We cannot
completely exclude the possibility that I ,25-(OH)2D3 can mobi-
lize intracellular calcium poois, because it is possible that
intracellular calcium pools might be rapidly depleted in the
absence of extracellular calcium; however, the short duration of
extracellular calcium removal made this unlikely.
[Cal, is considered to be an important component in regulat-
ing PTH secretion [121, but recent reports also indicate a
dissociation between a change in [Ca]1 and PTH secretion
[13—16]. Moreover, previous studies from our laboratory dem-
onstrated that 1 ,25-(OH)2D3 did not affect PTH secretion
acutely in vitro [61, indicating that l,25-(OH)2D3 increased [Cal1
without acutely suppressing PTH secretion. Our findings sug-
gest that [Ca] is not a universal factor that regulates FFH
secretion in parathyroid cells, raising the possibility that some
other, as yet unidentified, intracellular signal plays an important
role in regulating PTH secretion. The biological action of
increased [Cal1 induced by exposure to I ,25-(OH)2D3 remains
unclear.
Recent studies demonstrated the suppressive effect of long
term incubation with l,25-(OH)2D3 on PTH secretion [4,5].
Silver et al demonstrated that 1 ,25-(OH)2D3 decreased the
levels of pre-pro-PTH mRNA, probably by acting on DNA
transcription, resulting in a decreased PTH synthesis [27,281.
Since changes in [Ca] mediate a variety of hormonal processes
in addition to hormone secretion, it is possible that 1,25-
(OH)2D3-induced increase in [Cal1 might mediate its effect on
pre-pro-PTH mRNA. Further studies are necessary to clarify
the functional role of the 1 ,25-(OH)2D3-induced increase in
[Ca]1. Finally, the present studies suggest that 1,25-(OH)2D3
plays a role in regulating not only extracellular but also intra-
cellular calcium homeostasis in parathyroid cells.
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